[
  {
    "ts": null,
    "headline": "Boston Scientific (BSX) Garnering Bullish Views Amid Penumbra Acquisition",
    "summary": "Boston Scientific Corporation (NYSE:BSX) is one of the 12 best Medical Devices stocks to invest in according to Hedge Funds. On January 16, Richard Newitter from Truist Securities reiterated his Buy rating on Boston Scientific Corporation (NYSE:BSX). He set a price target of $120, implying almost 28% upside. The analyst attributed his rating to the […]",
    "url": "https://finnhub.io/api/news?id=0073a9ed93718a657d8e23f6c8b266a9e22098ef7c11bfb0c3d636096c2e98f0",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769801498,
      "headline": "Boston Scientific (BSX) Garnering Bullish Views Amid Penumbra Acquisition",
      "id": 138308935,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Boston Scientific Corporation (NYSE:BSX) is one of the 12 best Medical Devices stocks to invest in according to Hedge Funds. On January 16, Richard Newitter from Truist Securities reiterated his Buy rating on Boston Scientific Corporation (NYSE:BSX). He set a price target of $120, implying almost 28% upside. The analyst attributed his rating to the […]",
      "url": "https://finnhub.io/api/news?id=0073a9ed93718a657d8e23f6c8b266a9e22098ef7c11bfb0c3d636096c2e98f0"
    }
  },
  {
    "ts": null,
    "headline": "SENS Stock Up as Eversense 365 CGM Wins European CE Mark Approval",
    "summary": "Senseonics stock jumps after Eversense 365 wins CE Mark, expanding Europe access for its one-year CGM and strengthening the long-term growth outlook.",
    "url": "https://finnhub.io/api/news?id=6f24e455d2ac3cb55080f0f1005e1f640127f62195c45dbea83b0fb3420ef5d3",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769792820,
      "headline": "SENS Stock Up as Eversense 365 CGM Wins European CE Mark Approval",
      "id": 138308936,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Senseonics stock jumps after Eversense 365 wins CE Mark, expanding Europe access for its one-year CGM and strengthening the long-term growth outlook.",
      "url": "https://finnhub.io/api/news?id=6f24e455d2ac3cb55080f0f1005e1f640127f62195c45dbea83b0fb3420ef5d3"
    }
  },
  {
    "ts": null,
    "headline": "SYK Stock Gains as Q4 Earnings & Sales Beat on Strong Mako Adoption",
    "summary": "SYK shares rise after fourth-quarter EPS and sales top estimates, fueled by double-digit organic growth and strong adoption of its Mako platform.",
    "url": "https://finnhub.io/api/news?id=43e58a74a5198069f83b18fd9e11dd2cb1c2b07e9fdf181d609e43efeeeaeb5f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769786700,
      "headline": "SYK Stock Gains as Q4 Earnings & Sales Beat on Strong Mako Adoption",
      "id": 138307404,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "SYK shares rise after fourth-quarter EPS and sales top estimates, fueled by double-digit organic growth and strong adoption of its Mako platform.",
      "url": "https://finnhub.io/api/news?id=43e58a74a5198069f83b18fd9e11dd2cb1c2b07e9fdf181d609e43efeeeaeb5f"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific (BSX) Q4 Earnings on the Horizon: Analysts' Insights on Key Performance Measures",
    "summary": "Beyond analysts' top-and-bottom-line estimates for Boston Scientific (BSX), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended December 2025.",
    "url": "https://finnhub.io/api/news?id=3bb2df9e961e2c2a57562e99ffb987c8dc78d3e5b90821a5ccb84864c18c7fb5",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769782509,
      "headline": "Boston Scientific (BSX) Q4 Earnings on the Horizon: Analysts' Insights on Key Performance Measures",
      "id": 138307405,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Beyond analysts' top-and-bottom-line estimates for Boston Scientific (BSX), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended December 2025.",
      "url": "https://finnhub.io/api/news?id=3bb2df9e961e2c2a57562e99ffb987c8dc78d3e5b90821a5ccb84864c18c7fb5"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific Expands Neuromodulation And Obesity Trials As Valuation Stays Rich",
    "summary": "Boston Scientific (NYSE:BSX) is expanding its neuromodulation presence through the acquisitions of Nalu Medical and Valencia Technologies. The company recently shared new clinical data on spinal cord stimulation therapies for pain management. Boston Scientific also launched a clinical study in Asia to evaluate the OverStitch NXT device for obesity treatment. Boston Scientific, trading at $92.33, is moving further beyond its traditional cardiology roots into neurology and obesity treatment...",
    "url": "https://finnhub.io/api/news?id=61140bf718655cd616deebfd94b159dbe2d680f992ceb40270cfd4e302644163",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769778717,
      "headline": "Boston Scientific Expands Neuromodulation And Obesity Trials As Valuation Stays Rich",
      "id": 138305411,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Boston Scientific (NYSE:BSX) is expanding its neuromodulation presence through the acquisitions of Nalu Medical and Valencia Technologies. The company recently shared new clinical data on spinal cord stimulation therapies for pain management. Boston Scientific also launched a clinical study in Asia to evaluate the OverStitch NXT device for obesity treatment. Boston Scientific, trading at $92.33, is moving further beyond its traditional cardiology roots into neurology and obesity treatment...",
      "url": "https://finnhub.io/api/news?id=61140bf718655cd616deebfd94b159dbe2d680f992ceb40270cfd4e302644163"
    }
  },
  {
    "ts": null,
    "headline": "Nuwellis Appoints Carisa Schultz as Chief Financial Officer",
    "summary": "Schultz brings public company healthcare finance and medical technology experience to support Nuwellis’ next phase of growthMINNEAPOLIS, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE) a medical technology company focused on advancing precision cardiorenal care, today announced the appointment of Carisa Schultz as Chief Financial Officer, effective February 2, 2026. Ms. Schultz brings extensive healthcare and public company finance leadership experience, most recently serving as",
    "url": "https://finnhub.io/api/news?id=b21450adef5849dda932cd921ab255629bbe00db673eeefabf933da27c5a4ecc",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769778000,
      "headline": "Nuwellis Appoints Carisa Schultz as Chief Financial Officer",
      "id": 138305412,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Schultz brings public company healthcare finance and medical technology experience to support Nuwellis’ next phase of growthMINNEAPOLIS, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE) a medical technology company focused on advancing precision cardiorenal care, today announced the appointment of Carisa Schultz as Chief Financial Officer, effective February 2, 2026. Ms. Schultz brings extensive healthcare and public company finance leadership experience, most recently serving as",
      "url": "https://finnhub.io/api/news?id=b21450adef5849dda932cd921ab255629bbe00db673eeefabf933da27c5a4ecc"
    }
  }
]